Tocagen has filed to raise up to $86 million in an IPO to take its brain cancer gene therapy combination through the first part of a phase 2/3 trial.

Cancer therapeutics biotech BeyondSpring scored $54.3 million in a combination IPO and private placement. The total falls well short of its initial $100…

Nonprofit Parkinson’s UK has teamed up with the University of Sheffield to create a virtual biotech.

Buoyed by a third-round fundraising that netted $51.7 million, antibiotic developer Spero Therapeutics says it will be able to accelerate clinical development…

Deborah Dunsire has achieved the rare feat, on International Women’s Day no less, of becoming CEO of an early-stage biotech after being officially named as…

Hospital group Sanford Health has invested $20 million in InGeneron to support clinical trials of a stem cell regenerative medicine.

Arix Bioscience has teamed up with Takeda Ventures to create and grow biotechs.

In a typically fiery speech, President Donald Trump in his first joint address to Congress last night tore into the FDA’s “slow and burdensome approval process…

Pharma Two B has raised $30 million to complete a phase 3 trial of its Parkinson’s asset P2B001 and added ex-Pfizer CEO Jeff Kindler to its board.

Venture Capital